A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy
Publication
, Conference
Forde, B; Wallbillich, J; Havrilesky, LJ; Cohn, DE
Published in: Gynecologic Oncology
April 2015
Duke Scholars
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
April 2015
Volume
137
Start / End Page
24 / 24
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Forde, B., Wallbillich, J., Havrilesky, L. J., & Cohn, D. E. (2015). A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy. In Gynecologic Oncology (Vol. 137, pp. 24–24). Elsevier BV. https://doi.org/10.1016/j.ygyno.2015.01.056
Forde, B., J. Wallbillich, L. J. Havrilesky, and D. E. Cohn. “A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy.” In Gynecologic Oncology, 137:24–24. Elsevier BV, 2015. https://doi.org/10.1016/j.ygyno.2015.01.056.
Forde B, Wallbillich J, Havrilesky LJ, Cohn DE. A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy. In: Gynecologic Oncology. Elsevier BV; 2015. p. 24–24.
Forde, B., et al. “A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy.” Gynecologic Oncology, vol. 137, Elsevier BV, 2015, pp. 24–24. Crossref, doi:10.1016/j.ygyno.2015.01.056.
Forde B, Wallbillich J, Havrilesky LJ, Cohn DE. A personalized paradigm in the treatment of platinum-resistant ovarian cancer: A cost utility analysis of genomic-based versus cytotoxic therapy. Gynecologic Oncology. Elsevier BV; 2015. p. 24–24.
Published In
Gynecologic Oncology
DOI
ISSN
0090-8258
Publication Date
April 2015
Volume
137
Start / End Page
24 / 24
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis